Oruka Therapeutics, Inc. ORKA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s other income (expense)?
- Oruka Therapeutics, Inc. (ORKA) reported other income (expense) of $4.61M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Oruka Therapeutics, Inc.'s other income (expense) increased by 12.9% year-over-year, from $4.09M to $4.61M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.